Aspirin Primary Prevention Benefit vs Harm Calculator

Assess aspirin benefit vs. harm for primary cardiovascular prevention. USPSTF 2022: initiate low-dose aspirin for adults 40-59 with 10% or more 10-year CVD risk (Grade C, shared decision). Adults 60 or older: do not initiate (Grade D) due to increased bleeding outweighing benefit.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How to Use

Enter the values for the scenario you are assessing. Assess aspirin benefit vs. harm for primary cardiovascular prevention. USPSTF 2022: initiate low-dose aspirin for adults 40-59 with 10% or more 10-year CVD risk (Grade C, shared decision). Adults 60 or older: do not initiate (Grade D) due to increased bleeding outweighing benefit. Use the aspirin primary prevention result to inform your calculation.

Frequently Asked Questions